Anzeige
Mehr »
Mittwoch, 27.08.2025 - Börsentäglich über 12.000 News
Patentschutz bis in die 2040er - Biotech-Geheimtipp vor möglichem Fast-Track-Durchbruch in den USA!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C9B4 | ISIN: SE0017130826 | Ticker-Symbol: 06H
Stuttgart
27.08.25 | 09:41
3,080 Euro
+5,48 % +0,160
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BPC INSTRUMENTS AB Chart 1 Jahr
5-Tage-Chart
BPC INSTRUMENTS AB 5-Tage-Chart
PR Newswire
198 Leser
Artikel bewerten:
(1)

BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2025

LUND, Sweden, Aug. 27, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the half-year report for the period January 1 - June 30, 2025. The half-year report is available as an attached file to this release and on the company's website https://investor.bpcinstruments.com/financial-reports.

CEO Dr. Jing Liu comments: "The second quarter confirms the strength and relevance of our business. With 20 percent revenue growth in Q2 year-on-year and sustained profitability, we continue to expand with good margins from a platform and product portfolio that meet the needs of both industry and academia."

Q2 | 2025-04-01 - 2025-06-30

Net sales for the second quarter amounted to 16,879 (14,073) KSEK.

EBIT for the second quarter amounted to 2,436 (3,240) KSEK.

Net profit amounted to 2,003 (2,537) KSEK.

Earnings per share for the period amounted to 0.18 (0.24) SEK.

H1 | 2025-01-01 - 2025-06-30

Net sales for the period amounted to 30,019 (29,217) KSEK.

EBIT for the period amounted to 3,427 (9,573) KSEK.

Net profit amounted to 2,342 (8,199) KSEK.

Earnings per share for the period amounted to 0.21 (0.78) SEK.

At the end of the period equity/asset ratio was 93% (92%).

Total cash and equivalents, including long-term investments, amounted to 59,680 (25,410) KSEK.

Significant events Q2 2025

On 10 April, BPC announced the appointment of Hampus Darrell as new Chief Financial Officer.

On 23 April, BPC was awarded one of Sweden's leading environmental prizes for its innovative work in renewable energy and environmental biotechnology.

On 4 June, BPC received a 0.7 MSEK from KU Leuven, Belgium's highest-ranked university and one of the oldest and most renowned universities in Europe. The order includes several Gas Endeavour® III systems.

Highlights after the end of the period

On 21 July, BPC received an order from Cornell University in the United States valued at approximately SEK 1 million. The order includes two AMPTS® III Duo system. BPC's flagship instrument for conducting batch anaerobic fermentation tests.

On 5 August, BPC received an order from a research institute in the Philippines valued at approximately SEK 4.4 million. The order includes several BPC Blue® systems.

This information is such information that BPC Instruments AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation (MAR). The information was submitted, through the agency of the contact person below, for publication on 27 August, 2025.

For more information, please contact:
Dr. Jing Liu, CEO
BPC Instruments AB
Tel: +46 (0) 46 16 39 51
E-mail: ir@bpcinstruments.com

About BPC Instruments AB:

BPC Instruments is a global Swedish-based pioneering technology company developing and offering analytical instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing analysis. BPC Instruments' innovative products offer high-quality hardware and software based on deep knowledge and experience of target applications. The solutions are the first of their kind, making the company a pioneer in its field. Today, BPC Instruments exports to nearly 80 countries around the world. BPC is listed on the Spotlight Stock Market in Sweden. For more information, please visit BPC's webpage: www.bpcinstruments.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bpc-instruments-ab/r/bpc-instruments-reports-results-for-h1-and-q2-2025,c4223415

The following files are available for download:

https://mb.cision.com/Main/21129/4223415/3627928.pdf

BPC_Q2_2025

https://mb.cision.com/Public/21129/4223415/b7948cc92c51db2f.pdf

Press release - BPC Q2

Cision View original content:https://www.prnewswire.co.uk/news-releases/bpc-instruments-reports-results-for-h1-and-q2-2025-302539797.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.